Kowa Supplement: EMERGING MONOFOCAL INTRAOCULAR LENSES IN EUROPE:

Intraocular lens (IOL) technology has evolved dramatically during recent years due to the development of injectors that insert a folded IOL into the eye through a small incision. This allows fast, reliable, reproducible and controlled insertion that avoids the need for stitches and reduces the risk of postoperative complications. A number of injectable hydrophobic monofocal IOLs are currently available in Europe.
This review compares the characteristics of these IOLs with Avansee – one of the most widely used IOLs in Japan that is due to be launched in Europe in 2014. Studies show that Avansee IOLs inserted using the fully preloaded AvanseePreset injector system are relatively quick and easy to insert with one hand. Once inserted in this way, Avansee IOLs provide high levels of corrected visual acuity, assume a stable position in the eye without exerting zonal stress or transformation of the capsular bag, and fully regain their optical properties after injection. Moreover, Avansee IOLs are associated with a low risk of infection and postoperative complications such as posterior capsule opacification (PCO) and endophthalmitis, and have a low propensity for glistenings over time.
Download Supplement - click here
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.